Panel hears bill to ease refill rules for certain injectable testosterone prescriptions
House Bill 126 would allow some patients who have demonstrated consistent use to receive 92‑day supplies of certain injectable androgen prescriptions after a 12‑month period of monthly fills, reducing travel and prescription costs for patients, while adding a prescriber attestation as a safeguard.
The full story
Representative Popovici Mueller introduced House Bill 126, a bipartisan measure intended to reduce the burden on patients who receive injectable androgen prescriptions that are federally scheduled. The bill would add a provision to the Controlled Drug Act permitting a 92‑day supply after a patient has previously filled 12 monthly prescriptions from the same medical practice over a one‑year period; the prescription would need to include a prescriber statement that the medication treats chronic low testosterone.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.